tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ALKS Stock Latest News

Alkermes Hold Rating: Balancing Strong Performance with Alixorexton Uncertainties
RatingsAlkermes Hold Rating: Balancing Strong Performance with Alixorexton Uncertainties
9d ago
ALKS
Alkermes’ Hold Rating: Balancing Strong Revenue Growth with Orexin Program Uncertainties
PremiumRatings
Alkermes’ Hold Rating: Balancing Strong Revenue Growth with Orexin Program Uncertainties
10d ago
ALKS
Alkermes Reports Strong Q2 2025 Financial Results
PremiumCompany Announcements
Alkermes Reports Strong Q2 2025 Financial Results
10d ago
ALKS
Alkermes Earnings Call: Strong Growth and Promising Trials
PremiumCompany Announcements
Alkermes Earnings Call: Strong Growth and Promising Trials
10d ago
ALKS
Alkermes price target lowered to $33 from $35 at BofA
PremiumThe Fly
Alkermes price target lowered to $33 from $35 at BofA
10d ago
ALKS
Alkermes’s Strong Financial Performance and Promising Pipeline Drive Buy Rating
PremiumRatingsAlkermes’s Strong Financial Performance and Promising Pipeline Drive Buy Rating
11d ago
ALKS
Alkermes’ Strong Q2 2025 Performance and Future Growth Potential Justify Buy Rating
Premium
Ratings
Alkermes’ Strong Q2 2025 Performance and Future Growth Potential Justify Buy Rating
11d ago
ALKS
Alkermes reports Q2 EPS 52c, consensus 38c
Premium
The Fly
Alkermes reports Q2 EPS 52c, consensus 38c
11d ago
ALKS
Alkermes plc (ALKS) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Alkermes plc (ALKS) Q2 Earnings Cheat Sheet
13d ago
ALKS
Alkermes Drug Update: Hold Rating Amid Positive Sleep Test Results and Cataplexy Concerns
PremiumRatings
Alkermes Drug Update: Hold Rating Amid Positive Sleep Test Results and Cataplexy Concerns
17d ago
ALKS
Alkermes Announces Positive Phase 2 Study Results
PremiumCompany Announcements
Alkermes Announces Positive Phase 2 Study Results
18d ago
8K
ALKS
Alkermes price target raised to $54 from $50 at Jefferies
PremiumThe Fly
Alkermes price target raised to $54 from $50 at Jefferies
18d ago
ALKS
Alkermes narcolepsy trial results ‘encouraging’ for Centessa, says Leerink
PremiumThe FlyAlkermes narcolepsy trial results ‘encouraging’ for Centessa, says Leerink
19d ago
ALKS
CNTA
Alkermes data has limitations, but ‘strong,’ says H.C. Wainwright
Premium
The Fly
Alkermes data has limitations, but ‘strong,’ says H.C. Wainwright
19d ago
ALKS
Verizon reports Q2 beat, Block to join S&P 500: Morning Buzz
Premium
The Fly
Verizon reports Q2 beat, Block to join S&P 500: Morning Buzz
19d ago
BA
BX
Alkermes Hold Rating: Balancing Promising NT1 Study Results with Competitive and Valuation Challenges
PremiumRatings
Alkermes Hold Rating: Balancing Promising NT1 Study Results with Competitive and Valuation Challenges
19d ago
ALKS
Alkermes narcolepsy study results ‘look clearly positive,’ says Stifel
PremiumThe Fly
Alkermes narcolepsy study results ‘look clearly positive,’ says Stifel
19d ago
ALKS
Alkermes selling off on limited data disclosure, says BofA
PremiumThe Fly
Alkermes selling off on limited data disclosure, says BofA
19d ago
TAK
ALKS
Needham sees Alkermes trading up on today’s narcolepsy data
PremiumThe Fly
Needham sees Alkermes trading up on today’s narcolepsy data
19d ago
ALKS
Alkermes’ Alixorexton Shows Promising Efficacy and Safety in VIBRANCE-1 Phase 2 Study, Earning Buy Rating
PremiumRatingsAlkermes’ Alixorexton Shows Promising Efficacy and Safety in VIBRANCE-1 Phase 2 Study, Earning Buy Rating
19d ago
ALKS
Alkermes announces Vibrance-1 study meets primary endpoint
Premium
The Fly
Alkermes announces Vibrance-1 study meets primary endpoint
19d ago
ALKS
DoorDash, Southwest downgraded: Wall Street’s top analyst calls
Premium
The Fly
DoorDash, Southwest downgraded: Wall Street’s top analyst calls
25d ago
R
GL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >